Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

Repurposed drugs offer a promising, safe, and effective acne treatment.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Five FDA-approved drugs may help block COVID-19 virus entry.

Drug repurposing finds new uses for existing drugs, saving time and money.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Donors on most medications can donate certain blood products without waiting, except for specific drugs that need a waiting period.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.